EA200200415A1 - Композиция фармацевтического носителя - Google Patents

Композиция фармацевтического носителя

Info

Publication number
EA200200415A1
EA200200415A1 EA200200415A EA200200415A EA200200415A1 EA 200200415 A1 EA200200415 A1 EA 200200415A1 EA 200200415 A EA200200415 A EA 200200415A EA 200200415 A EA200200415 A EA 200200415A EA 200200415 A1 EA200200415 A1 EA 200200415A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pvp
fatty acid
acid esters
value
sucrose fatty
Prior art date
Application number
EA200200415A
Other languages
English (en)
Russian (ru)
Inventor
Джозеф Киювунг Йоон
Ричард Уилльям Сондерс
Махди Бакир Фози
Original Assignee
Американ Цианамид Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Цианамид Компани filed Critical Американ Цианамид Компани
Publication of EA200200415A1 publication Critical patent/EA200200415A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA200200415A 1999-09-27 2000-09-26 Композиция фармацевтического носителя EA200200415A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
PCT/US2000/026381 WO2001022942A1 (en) 1999-09-27 2000-09-26 Pharmaceutical carrier formulation

Publications (1)

Publication Number Publication Date
EA200200415A1 true EA200200415A1 (ru) 2002-10-31

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200415A EA200200415A1 (ru) 1999-09-27 2000-09-26 Композиция фармацевтического носителя

Country Status (18)

Country Link
EP (1) EP1216029A1 (es)
JP (1) JP2003510267A (es)
KR (1) KR20020064289A (es)
CN (1) CN1399542A (es)
AR (1) AR025867A1 (es)
AU (1) AU7716100A (es)
BR (1) BR0014308A (es)
CA (1) CA2388471A1 (es)
CZ (1) CZ20021082A3 (es)
EA (1) EA200200415A1 (es)
HK (1) HK1044485A1 (es)
HU (1) HUP0202652A3 (es)
IL (1) IL148543A0 (es)
MX (1) MXPA02003190A (es)
NO (1) NO20021476L (es)
PL (1) PL354331A1 (es)
WO (1) WO2001022942A1 (es)
ZA (1) ZA200203311B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2004073692A1 (ja) * 2003-02-18 2004-09-02 Yamashita, Shinji 難水溶性薬物のハードカプセル剤
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
JP5406529B2 (ja) 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
EP2068829A2 (en) * 2006-10-31 2009-06-17 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
US11389383B2 (en) 2017-12-20 2022-07-19 Firmenich Sa Oral care compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
EP1049459B1 (en) * 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
AR025867A1 (es) 2002-12-18
ZA200203311B (en) 2003-12-31
IL148543A0 (en) 2002-09-12
BR0014308A (pt) 2002-05-21
HUP0202652A3 (en) 2004-06-28
HK1044485A1 (zh) 2002-10-25
MXPA02003190A (es) 2002-09-30
AU7716100A (en) 2001-04-30
JP2003510267A (ja) 2003-03-18
CN1399542A (zh) 2003-02-26
NO20021476D0 (no) 2002-03-25
HUP0202652A2 (hu) 2004-05-28
CZ20021082A3 (cs) 2002-06-12
CA2388471A1 (en) 2001-04-05
KR20020064289A (ko) 2002-08-07
EP1216029A1 (en) 2002-06-26
PL354331A1 (en) 2004-01-12
WO2001022942A1 (en) 2001-04-05
NO20021476L (no) 2002-04-16

Similar Documents

Publication Publication Date Title
ECSP045496A (es) "preparaciones acidas de insulina con estabilidad mejorada"
ATE331517T1 (de) Pharmazeutische zusammenstellungen
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
NO304261B1 (no) Preparat omfattende en lipofil forbindelse
ES2187820T3 (es) Formulaciones farmaceuticas de factor de liberacion de la corticotrop ina que tiene una estabilidad en su forma liquida.
EA200200415A1 (ru) Композиция фармацевтического носителя
IL155788A (en) A highly purified ifn – β active and mannitol-containing preparation, a method to make an improved stability of ifn – β active, and a method to enhance the stability of ifn – β in biologically active formulation.
WO2001093816A3 (en) Stabilized compositions containing oxygen-labile active agents
CA2216277A1 (en) Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
ATE290876T1 (de) Pharmazeutische zusammensetzung enthaltend cyclosprin als aktiven bestandteil
AU2001291731A1 (en) Pharmaceutical, effervescent formulation containing ramipril
WO2001022969A3 (en) Vasopressin agonist formulation and process
AU2809697A (en) Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
CA2423572A1 (en) Stabilization of solid thyroid drug formulations
AU2002214223A1 (en) Long-acting cytokine derivatives and pharmaceutical compositions comprising them
SE9902742D0 (sv) New pharmaceutical formultion
JP2003526680A5 (es)
EA200200414A1 (ru) Композиция антагониста вазопрессина и способ ее получения
WO2001003774A3 (en) Pharmaceutical composition for the treatment of calcification
RU2003125096A (ru) Психостимулирующее средство
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
ES2118033A1 (es) Formulacion farmaceutica antiinflamatoria.
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina